NGL Fine Chem P/B Ratio
NGL Fine Chem (NGLFINE) P/B ratio is 5.88 (High), book value per share ₹1096.67 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see NGL Fine Chem share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NGLFINE P/B Ratio — Valuation Insights & Book Value Analysis
NGL Fine Chem price-to-book ratio interpretation, valuation status and historical context — current P/B 5.88 (High). Review NGLFINE price earnings ratio to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 5.88, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 150.0% above historical average
- Trading at premium to sector average PB of -0.31
NGL Fine Chem P/B Ratio Historical Trend
NGLFINE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View NGL Fine Chem yearly highs lows for the annual high/low range and current price position.
NGLFINE Historical P/B Ratio — Book Value Per Share & Year-End Price
NGL Fine Chem annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.92 | ₹1096.67 | ₹3205.50 | ₹329 | Moderate |
| 2025 | 1.5 | ₹940.0 | ₹1406.20 | ₹282 | Moderate |
| 2024 | 2.07 | ₹876.67 | ₹1811.15 | ₹263 | Moderate |
| 2023 | 3.0 | ₹743.33 | ₹2230.45 | ₹223 | High |
| 2022 | 2.27 | ₹676.67 | ₹1536.10 | ₹203 | Moderate |
NGLFINE vs Healthcare Peers — P/B Ratio Comparison
NGL Fine Chem P/B 5.88 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |